Published in Obesity and Diabetes Week, February 14th, 2005
According to a study from Egypt, "The effect of various doses (0, 10, 20, 40, or 80 mg/kg body weight) of naringin (a citrus flavonone) was studied on streptozotocin (STZ)-induced hyperglycemic rats to evaluate the possible hypoglycemic and antioxidant activity of naringin in diabetes."
"In comparison to the normoglycemic group the treatment of rats with a single dose of STZ (65 mg/kg body weight) only revealed a significant increase (p<0.05) in plasma hydrogen peroxide (H2 O2 ) by 230%, increased the thiobarbituric acid reactive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week